PE firm TPG Capital said to mull stake sale in IPO-bound Pathology Asia

PE firm TPG Capital said to mull stake sale in IPO-bound Pathology Asia

Photo from Pathology Asia's website.

Private equity firm TPG Capital Asia is considering selling a 20% stake in Pathology Asia Holdings, its pathology portfolio in the region, ahead of the unit’s initial public offering (IPO), according to a Bloomberg report.